WELCOME TO G-FINDER

The G-FINDER survey tracks global public, private, and philanthropic investment into product research and development (R&D) for neglected diseases. These are diseases that predominantly affect developing countries and for which products are needed but there is insufficient commercial incentive to stimulate R&D.

Additionally, the survey tracks investment into product R&D for emerging infectious diseases (EIDs). The list of diseases included is based on the priority pathogens identified in the WHO R&D Blueprint.

The survey includes R&D of drugs, vaccines, diagnostics, vector control products and microbicides, from basic research through to post-registration studies.

The project is conducted by Policy Cures Research and funded by the Bill & Melinda Gates Foundation. For more information, please refer to the frequently asked questions.




G-FINDER Reports

Survey results are published and launched as yearly G-FINDER reports.

G-FINDER reports from previous years:

2017. Neglected Disease Research & Development: Reflecting on a decade of global investment

2016. Neglected Disease Research & Development: A pivotal moment for global health

2015. Neglected Disease Research & Development: The Ebola effect

2014. Neglected Disease Research & Development: Emerging trends

2013. Neglected Disease Research & Development: The public divide

2012. Neglected Disease Research & Development: A five year review

2011. Neglected Disease Research & Development: Is innovation under threat?

2010. Neglected Disease Research & Development: Is the global financial crisis changing R&D

2009. Neglected Disease Research & Development: New times, new trends

2008. Neglected Disease Research & Development: How much are we really spending?


G-FINDER Public Search Tool

The underlying data behind the G-FINDER reports is also made freely available via the G-FINDER public search tool. Confidential industry data is aggregated and anonymised.


Key dates


22 June 2018
Deadline for completing the survey

SURVEY CLOSED

December 2018 
Publication and global launch of the eleventh annual report


0 days left to complete the survey.

SURVEY CLOSED